Loreal 2013 Annual Report Download - page 81

Download and view the complete annual report

Please find page 81 of the 2013 Loreal annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 96

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96

PROVEN ANTI-AGEING
EFFICACY
2000 – 2006
First proofs of efficacy.
Its performance at 3% on skin
elasticity and tone
is demonstrated both in vitro
and in vivo.
2009 – 2012
New proofs of efficacy:
Advanced Research continues
to enrich the cluster of proofs
ofthe anti-ageing performance
of Pro-Xylane™. Its mechanism
of action on GAGs is
demonstrated, and an in vivo
clinical trial concludes
thatthere is a visible reduction
in lines and pores, along
withevenness of complexion.
2013
Revitalift Laser X3
is a worldwide success
and enables the L’ORÉAL PARIS
brand to post strong
market share increases.
Meanwhile, the Pro-Xylane™
saga continues.
New properties
arebrought to light,
andresearchers strive
toenhance availability
inthe skin by adjusting
formulation and
associations.
2012
In a clinical trial, the laboratories compare
over two months the efficacy of a rejuvenation
laser session with a skincare product
containing Pro-Xylane™ at 3%, associated
with two other active ingredients. Revitalift Laser X3,
launched by L’ORÉAL PARIS, claims a triple action
on lines, skin quality and facial contours.
MOLECULE TO THE WORLDWIDE SUCCESS OF REVITALIFT LASER X3
2011
An increasingly accessible molecule.
The challenge is to ensure that
this very expensive molecule
can be accessible to a mass-market
brand. By optimising the synthesis
of Pro-Xylane™, the laboratories manage
to reduce its cost by three quarters.
79